Consistent with those anti-cancer effects, several groups have reported that niclosamide suppresses β-catenin mediated canonical Wnt signaling, through means such as inhibited TCF/LEF transcriptional activity and down-regulated pathway target genes, e.g., Axin2 [10,12,16,17]. The gene discussed is HNF4A; the disease is cancer.